ANTI-INFLAMMATORY PROFILE OF STRUCTURAL ANALOGUE OF CANNABIDIOL IN A PRE-CLINICAL MODEL OF INFLAMMATION

Vol. 1 2024 - 316808
Poster - V Workshop on Inflammation
Favorite this paper
How to cite this paper?
Abstract

The prolonged use of NSAIDs or SAIDs in the treatment of certain pathologies can lead to numerous side effects. Therefore, the goal of chemists is to discover new molecules with effective results and fewer side effects. Cannabidiol has been explored as a therapeutic agent for various disorders, demonstrating anti-inflammatory, immunomodulatory, and analgesic properties. Female Swiss Webster mice (28-32 g, n = 6-8) were injected with carrageenan for evaluate the anti-inflammatory effects and treated orally with the analogue (PQM-290) at doses of 1, 3 and 10 μmol/kg. One hour later, they received an injection of carrageenan (0.5%, 1 mL) or saline (NaCl 0.9%) into the SAP (subcutaneous air pouch). After 24 hours, the animals were euthanized, and the SAP exudate was collected for leukocyte counts and cytokine measurement. Results are presented as mean ± SD. Statistical analysis was performed by ANOVA followed by Tukey's test (*p<0.05). The protocol for the use of animals was approved by CEUA/UFRJ and received number 35/19. Carrageenan injected in SAP led to an increase in cellularity (129±19.5x10³cells/μL) when compared to the saline-injected group (3.12±1.6x10³cells/μL). The group of animals treated with PQM significantly reduced leukocyte migration, as follows: PQM-290 1μmol/kg: 83.6±15*x10³cells/μL; 3μmol/kg: 129.9±40.8 x10³cells/μL; 10μmol/kg: 98.8±14.4x10³cells/μL. Dexamethasone (9 μmol/kg) treatment also resulted in a reduction: 53.5±18.8*x10³cells/μL. Carrageenan injection into SAP resulted in an increase in IL-6 levels (965.4±233 pg/mL) when compared to the vehicle-treated group (53±21.5 pg/mL). The pre-treatment with dexamethasone did significantly reduced IL6 production (344.4±203*pg/mL). All three doses of PQM-290 also demonstrated significant effect: 1μmol/kg: 425.1±105.2*pg/mL; 3μmol/kg: 185.5±117.1*pg/mL; 10μmol/kg: 33.5±21*pg/mL. Results suggest that cannabidiol-based molecule has anti-inflammatory potencial reducing some parameters of acute inflammation.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Federal University of the State of Rio de Janeiro
  • 2 Federal University of Alfenas (UNIFAL)
  • 3 Federal University of Rio de Janeiro (UFRJ)
  • 4 Federal University of Rio de Janeiro
  • 5 Universidade Federal do Rio de Janeiro
Track
  • New Therapies
Keywords
acute inflammation
Cannabidiol (CBD)
inflammation
cell migration
cannabinoids